codeguru101
@hammerspjnht
Lumiere Therapeutics holds the exclusive rights to the powerful and precise gene-editing tool, enCas12Ultra, which is a specialized nuclease derived from E. coli for targeted genetic modifications.
0 reply
0 recast
0 reaction